Da 13.06.2019 14:00 fino a quando 13.06.2019 18:00
a Sala convegni Fondazione EBRIS
Postato da Amministrazione
https://bit.ly/2W44XZu
Categorie: Sanità
Visite: 1369
Sala convegni Fondazione EBRIS
Via De Renzi, 50 Salerno
The Conference will be accredited for N. 50 italian following professionals:
ECM N° 261062 - CREDITS: 4 - Acquisition of Credits under current Age.na.s legislation
Registrations exclusively through the website www.strategieonweb.it
RATIONALE
Today the immuno-oncology (I-O) represents a revolution in the field of oncology.
The checkpoints inhibitors (anti-CTLA4, anti-PD-1, etc.), are able to kill cancer cells indirectly, through the interaction with the immune system cells. The characteristics of adaptability and memory of the immune-system make it able to reach longterm survival (more than 10 years). For this reason, I-O became the fourth pillars in the treatment of cancer together surgery, radiotherapy, and chemotherapy.
After the excellent results reached in different type of cancers, I-O is exploring a wide range of new molecules and possible combinations or sequencing, in order to increase the number of patients with a long-term benefit.
The intent of this course, with contributions from Società Campana di Immunoncologia (SCITO) is to offer a general educational overview about the topics described. In addition, thanks to the contribution of Karolinska Institute of Stockholm, this course goes beyond national borders taking on an international aspect.
PROGRAM
14.00 Welcome & Registration
14.30 Introduction and Objectives
Sabino De Placido - Clementina Savastano
SESSION: UPDATE AND NEW TRENDS IN CANCER IMMUNO-ONCOLOGY
14.45 Chair Vincenzo Montesarchio
Melanoma: Emerging strategies and future perspectives.
Speaker Paolo Antonio Ascierto
Debate
15.15 Chair Giacomo Cartenì
Immunotherapy evolution for lung carcinoma
Speaker Cesare Gridelli
Debate
15.45 Chair Giuseppe Palmieri
Immunotherapy in colorectal cancer: what's new
Speaker Antonio Avallone
Debate
16.15 Chair Corrado Caracò - Paolo Antonio Ascierto SCITO meets Karolinska Cancer Institute
The relevance of biomarkers as prognostic and predictive tools in immunotherapy - Pascale and KI collaboration Speaker Giuseppe Masucci
Innovative Diagnostics for Solid Tumors The Karolinska Institutet Model. Speaker Rolf Lewensohn
Debate
SESSION: SCITO YOUTH
16.45 Chair Ester Simeone Projects and activities Speaker Margaret Ottaviano Debate
17.15 ROUND TABLE: Inter-regional collaborations in cancer immunotherapy: ideas, proposals, opportunities
Chair Paolo Antonio Ascierto
Discussants: Michele Aieta, Andrea Botticelli, Michele Guida Evaristo Maiello, Gennaro Palmiotti
18.00 Conclusions: Clementina Savastano